In recent times, spinal fusion has gained popularity among surgeons due to their preference for machined bone products over autograft. As surgeons continue to appreciate the several clinical benefits of allografts, the market for bone graft products expects to grow immensely.
New analysis from Frost & Sullivan (medicaldevices.frost.com), U.S. Bone Grafts and Bone Graft Substitutes Markets, reveals that the market earned revenues of $1.3 billion in 2006 and estimates this to reach $3.3 billion in 2013.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Bone Grafts and Bone Graft Substitutes Markets, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.
The surfeit of orthobiological products in the United States has improved orthopedic surgeons’ familiarity with these products, encouraging the manufacturers of bone graft and bone grafts substitutes. Numerous clinical studies in this field have also encouraged surgeons to use the products.
"Surgeons who had been reluctant to use allograft and bone graft substitutes are attracted by the safety and reliability of these products," says Frost & Sullivan Research Analyst Aarti Shetty. "They also offer greater flexibility in treatment options and are cost-effective."
Moreover, autografts involve a supplementary procedure called ‘harvesting’, which exposes patients to high risks such as blood loss, infection, and pain. In contrast, allografts provide quick recovery, reduced blood loss, and morbidity, further persuading surgeons to switch to this mode of treatment.
With an increase in the number of spinal fusions and other orthopedic procedures, clinicians are competing for a limited supply of products due to a decline in bone donor population, placing additional pressure on the market. Lack of awareness and a negative attitude toward tissue donation after death has slowed the donor segment for over a decade, limiting the supply of cadaver tissue available for processing.
Another factor restraining the bone donor segment of the market is the increase in population of older generation. As elderly people suffer from conditions such as osteoporosis or cancer, their bones weaken and become unsuitable for donation.
Manufacturers need to focus their research and development groups on developing bone graft materials that are comparable to autografts. The growing bone grafts market is likely to replace the decreased supply of tissue donations, which is a roadblock to providing effective solutions to patients.
"It is imperative that tissue processing organizations maintain high quality in their processing methods to ensure the effective utilization of the limited resources of donation currently available", says Shetty. "The expertise of the tissue recovery team determines the quality and volume of donated tissue that is delivered to the processor."
Therefore, better training should be provided to recovery technicians to improve screening, procurement, and testing methods. Retrieval of the tissue in a timely manner and refrigeration in a shorter time span will reduce the possibility of tissue contamination, resulting in less rejection.
For-profit organizations could establish alliances with non-profit organizations to help recover more tissues as well as develop education plans and promotions to increase public awareness on the benefits of tissue donation.
Other advances in technology in terms of ease of use, patient comfort, and improved designs are also opening up several rewarding market opportunities.
U.S. Bone Grafts and Bone Graft Substitutes Markets is part of the Medical Devices Growth Partnership Service, which includes research service in the following markets: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Graft Substitutes and Platelet Concentrate Systems. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.